Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
CVS Health (CVS) subsidiary health insurer with 39M+ members; $69B acquisition integrating insurance with CVS pharmacies and MinuteClinic for care coordination competing with UnitedHealth in Medicare Advantage.
Aetna is a Hartford, Connecticut-based health insurance company and subsidiary of CVS Health (NYSE: CVS) — one of the largest US health insurers with 39+ million members, providing medical, dental, vision, pharmacy benefit management, and behavioral health coverage through employer-sponsored plans, Medicare Advantage, Medicaid managed care, and individual marketplace plans. CVS Health acquired Aetna for $69 billion in 2018, creating a vertically integrated healthcare company combining insurance, pharmacy retail, pharmacy benefit management (PBM), and MinuteClinic health services.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.